According to the terms of the agreement, Sanofi will acquire London-based Vicebio’s entire share capital for an upfront ...

Sanofi has signed an agreement to acquire UK-based biotechnology company Vicebio’s share capital for $1.15bn upfront, to expand its vaccine development capabilities. The deal also includes additional ...

Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors like ...

An update from BB Biotech ( ($CH:BION) ) is now available. In Q2 2025, BB Biotech outperformed the Nasdaq Biotech Index, with a 10.2% increase in ...

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...

People are buying weight loss drugs online but the cut-price deals may not be what they seem to be, health chiefs warned.

On July 12, a new deadly Nipah virus infection was confirmed in a 52-year-old man in the Palakkad district of Kerala, marking ...

A 2025 survey of over 150 drug developers reveals that multi-indication development strategies have become central to the ...

But as she explained, African-led innovators are working to close these gaps through technology, data and new business models ...

The Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA) has urged all stakeholders to come together to shape a future ...